Canadian Facial Reanimation Services: An Exploratory National Survey
Plastic Surgery · 15.04.2026
DOI: 10.1177/22925503261440510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plastic Surgery, online erschienen am 15.04.2026. Verfasst von Catherine F Roy und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head & Neck Surgery, McGill University Health Centre, Montreal, QC, CA. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Reanimation
Abstract (Originalsprache)
Background
Canada has a strong historical legacy in facial reanimation, yet few comprehensive programs exist nationally. Facial reanimation requires specialized expertise, multidisciplinary care, and resource-intensive interventions, which naturally centralize services in high-volume centers. Conversely, timely assessment and longitudinal follow-up are essential, creating challenges in a geographically vast country with provincially siloed healthcare systems. This study aimed to characterize the availability, structure, and perceived barriers to facial reanimation care across Canadian academic centers.
Methods
A 15-item cross-sectional survey was distributed to department heads or delegates from Canadian university-affiliated plastic surgery (N = 15) and otolaryngology departments (N = 12). The survey assessed available services, multidisciplinary resources, outcome tracking, and perceived barriers. Responses were collected anonymously using REDCap and analyzed descriptively.
Results
Fifteen of 27 departments responded (55.6%), representing six provinces. Core interventions including static suspension, periocular procedures, and nerve transfers were widely available. Cross-facial nerve grafting (80%), regional muscle transfer (67%), and free muscle transfer (73%) were less consistently offered. Only 53% of departments performed surgical procedures for non-flaccid facial paralysis. Outcome evaluation relied primarily on clinician-graded scales and subjective patient reports, with limited use of validated patient-reported outcome measures and standardized photo/video documentation. Half of centers reported a formal multidisciplinary team, with variable access to neuromuscular retraining therapists and psychologists. Common barriers included limited awareness among referring physicians, restricted operating room time, and insufficient allied health resources.
Conclusion
Canadian centers provide broad access to foundational facial reanimation interventions, but gaps remain in advanced procedures, multidisciplinary support, and standardized outcomes tracking. Respondents unanimously supported expanding facial reanimation services.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology Head & Neck Surgery, McGill University Health Centre, Montreal, QC, CA.
- Hadlock Center for Facial Plastic Surgery, Boston, MA, USA.
- University of Toronto, Department of Surgery, Division of Plastic, Reconstructive & Aesthetic Surgery, 149 College Street, Toronto, ON, Canada, M5 T 1P5.
- University Health Network, Toronto Western Hospital, Department of Surgery, Division of Plastic, Reconstructive & Aesthetic Surgery, 399 Bathurst Street, Toronto, ON, Canada, M5 T 2S8.
- Department of Otolaryngology Head & Neck Surgery, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
ORCID-Profile: Catherine F Roy
Zitieren
APA
Roy, C. F., Baltzer, H., Hadlock, T. A., & Mascarella, M. M. (2026). Canadian Facial Reanimation Services: An Exploratory National Survey. Plastic Surgery. https://doi.org/10.1177/22925503261440510
Vancouver
Roy CF, Baltzer H, Hadlock TA, Mascarella MM. Canadian Facial Reanimation Services: An Exploratory National Survey. Plastic Surgery. 2026. doi:10.1177/22925503261440510
BibTeX
@article{Roy2026,
author = {Roy, Catherine F and Baltzer, Heather and Hadlock, Tessa A and Mascarella, Marco M},
title = {Canadian Facial Reanimation Services: An Exploratory National Survey},
journal = {Plastic Surgery},
year = {2026},
doi = {10.1177/22925503261440510}
}
EUVIMED